To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!

Reproductive BioMedicine Online

Volumn 31, Issue 1, 2015, Pages 6-8

  Griesinger, Georg ^a   Venetis, Christos A ^b   Tarlatzis, Basil ^c   Kolibianakis, Efstratios Michaelis ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

GnRH antagonist; oral contraceptive pill; ovarian stimulation; pregnancy rat

Indexed keywords

DESOGESTREL; ETHINYLESTRADIOL; GONADORELIN ANTAGONIST; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN; GONADORELIN;

ARTICLE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; PREGNANCY RATE; SAMPLE SIZE; ANTAGONISTS AND INHIBITORS; FEMALE; PREGNANCY;

CONTRACEPTIVES, ORAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; PREGNANCY;

EID: 84933677450     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2015.04.001     Document Type: Note

References (9)

1. I. Cédrin-Durnerin, B. Bständig, I. Parneix, V. Bied-Damon, C. Avril, C. Decanter, and J.N. Hugues Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol Hum. Reprod 22 2007 109 116
2. J.A. Garcia-Velasco, and H.M. Fatemi To pill or not to pill in GnRH antagonist cycles: that is the question! Reprod. Biomed. Online 30 2015 39 42
3. J.A. Garcia-Velasco, A. Bermejo, F. Ruiz, J. Martinez-Salazar, A. Requena, and A. Pellicer Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial Fertil. Steril 96 2011 590 593
4. G. Griesinger, E.M. Kolibianakis, C. Venetis, K. Diedrich, and B. Tarlatzis Oral contraceptive pre-treatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis Fertil. Steril 94 2010 2382 2384
5. J.A. Huirne, A.C. van Loenen, J. Donnez, C. Pirard, R. Homburg, R. Schats, J. McDonnell, and C.B. Lambalk Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study Reprod. Biomed. Online 13 2006 235 245
6. C.H. Kim, G.H. Jeon, Y.P. Cheon, I. Jeon, S.H. Kim, H.D. Chae, and Kang B.M. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pre-treatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection Fertil. Steril 92 2009 1758 1760
7. E.M. Kolibianakis, E.G. Papanikolaou, M. Camus, H. Tournaye, A.C. Van Steirteghem, and P. Devroey Effect of oral contraceptive pill pre-treatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial Hum. Reprod 21 2006 352 357
8. E. Tavmergen, E. von Mauw, H. Witjes, and B. Mannaerts., 2011 Outcome of a trial to identify predictive factors for ovarian response in a GnRH antagonist protocol with or without oral contraceptive scheduling. Abstracts of the 25th Annual Meeting of ESHRE, Amsterdam, the Netherlands, 28 June - 1 July, 2009, Hum Reprod 2009;24 (Supplement 1):i85 [O-211];
9. full publication: Andersen AN, Witjes H, Gordon K, Mannaerts B; Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment Hum. Reprod 26 3413 3423